India to Brazil: Ustekinumab Export Trade Route

The India to Brazil Ustekinumab corridor is one of India's established pharmaceutical export routes, with 236 shipments documented worth a combined $909.9K USD. The route is dominated by NIVIRA EXPORTS, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $3.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with ustekinumab's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 26.4%, placing it at rank #14 among India's top ustekinumab export destinations globally.

On the import side, key buyers of Indian ustekinumab in Brazil include AS PER INVOICE BRAZIL, TO THE ORDER,, TO THE ORDER and 62 others. AS PER INVOICE BRAZIL is the single largest importer with 50 shipments valued at $112.2K USD.

India's ustekinumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. NIVIRA EXPORTS with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NIVIRA EXPORTS, GNH INDIA PHARMACEUTICALS LIMITED, VAMA LIFECARE PRIVATE LIMITED — together account for 68% of total trade value on this route. The average shipment value of $3.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as medicines: harmless pharmaceutical medicine going for human consumption each mlcontains: ustekinumab solution for injec and pharmaceutical medicine each pack contains single pfs of ustekinumab 90mg stelara, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AS PER INVOICE BRAZIL is the largest importer with 50 shipments worth $112.2K USD — representing 12% of all ustekinumab imports from India on this route. A total of 65 buyers are active on this corridor.